Zhen Bo Su
Director/Miembro de la Junta en CASI PHARMACEUTICALS, INC. .
Perfil
Mr. Zhen Bo Su is an Independent Director at CASI Pharmaceuticals, Inc., a Managing Partner at Shenzhen Share Investment LP and a Partner at Redhill Capital Investment Management Co. Ltd.
He is on the Board of Directors at CASI Pharmaceuticals, Inc. and Shenzhen Share Investment LP.
Mr. Su was previously employed as a Co-Founder by Chongqing TCR CURE Biopharma Technology Co., Ltd.
He received his undergraduate degree from Guangdong Medical University, a graduate degree from Sun Yat-Sen University and an MBA from The University of Chicago.
Cargos activos de Zhen Bo Su
| Empresas | Cargo | Inicio |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 21/03/2023 |
Shenzhen Share Investment LP
 Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Director/Miembro de la Junta | - |
| Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Zhen Bo Su.
| Empresas | Cargo | Fin |
|---|---|---|
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Fundador | - |
Formación de Zhen Bo Su.
| The University of Chicago | Masters Business Admin |
| Sun Yat-Sen University | Graduate Degree |
| Guangdong Medical University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Chongqing TCR CURE Biopharma Technology Co., Ltd
Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
| Redhill Capital Investment Management Co. Ltd. | |
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Finance |
- Bolsa de valores
- Insiders
- Zhen Bo Su
